Chemotherapy-Induced Nausea and Vomiting: Emerging Therapies and New Guidelines
This activity is supported by an educational grant from Eisai, Inc.
Diagnosing and Treating Chemotherapy-Induced Nausea and Vomiting: Understanding the Need and Clinical Data for Best Patient Care
Hope S. Rugo, MDProfessor of MedicineDirector, Breast Oncology Clinical Trials EducationDepartment of Medicine, Division of Hematology/OncologyUniversity of California San Francisco Medical CenterSan Francisco, California
Current Clinical Practice for Chemotherapy-Induced Nausea and Vomiting: Understanding the Up-to-Date Evidence-Based Guidelines for Prevention and Treatment
Una Hopkins, RN, DNPAssistant Professor, New York University NursingAdministrative Director, White Plains Hospital Cancer CenterWhite Plains, New York
Contributing Editorial Support
Anna Azyolinsky, PhDMedical ConsultantNew York, New York
Beatriz Manzor Mitrzyk, PharmD, BCPSMedical ConsultantNorthville, Michigan
Activity Overview
This activity is designed to educate oncologists and oncology nurses on the optimal management of chemotherapy-induced nausea and vomiting (CINV), education on the efficacy and safety data for current and emerging agents for the treatment of CINV, and current guidelines for management of CINV.
To continue this CME, click here.
Management of Immune-Related Toxicities in Melanoma Has Improved Over Time
April 24th 2024During a Case-Based Roundtable® event, Evan J. Lipson, MD, discussed with participants how their experience with immunotherapy toxicities has changed over time in the first article of a 2-part series.
Read More
Emphasizing the Need for NGS in Advanced NSCLC to Determine Treatment
April 23rd 2024During a Case-Based Roundtable® event, Joshua Sabari, MD, led a discussion on the need for next-generation sequencing to determine treatment in patients with EGFR-positive advanced non–small cell lung cancer in the first article of a 2-part series.
Read More
